May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Bestrophin-2 and Generation of Intraocular Pressure
Author Affiliations & Notes
  • Y. Zhang
    Department of Ophthalmology & Vision Science, University of Arizona, Tucson, Arizona
  • B. Bakall
    Department of Ophthalmology & Vision Science, University of Arizona, Tucson, Arizona
  • P. McLaughlin
    Department of Ophthalmology & Vision Science, University of Arizona, Tucson, Arizona
  • L. Y. Marmorstein
    Department of Ophthalmology & Vision Science, University of Arizona, Tucson, Arizona
  • A. Marmorstein
    Department of Ophthalmology & Vision Science, University of Arizona, Tucson, Arizona
    College of Optical Sciences, Tucson, Arizona
  • Footnotes
    Commercial Relationships  Y. Zhang, None; B. Bakall, None; P. McLaughlin, None; L.Y. Marmorstein, None; A. Marmorstein, None.
  • Footnotes
    Support  NIH (EY13160 to ADM, EY13847 to LYM), the Foundation, Synfrämjandet and the Swedish Research Council (BB), an unrestricted grant to the Department of Ophthalmology at U of A from RPB
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5862. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Zhang, B. Bakall, P. McLaughlin, L. Y. Marmorstein, A. Marmorstein; Bestrophin-2 and Generation of Intraocular Pressure. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5862.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Bestrophin-2 (Best2) is expressed in the non-pigmented epithelial (NPE) cells of the ciliary body. Nothing is known of its physiological function in the eye. The purpose of this study was to determine whether the absence of Best2 affects aqueous humor dynamics in Best2 knock-out mice.

Methods: : We have previously reported on the generation of Best2-/- mice and the localization of Best2 gene and protein expression to NPE cells. IOP measurements were made by cannulation of the anterior chamber. Measurements were made in mice aged 2-4 months and performed between 2:00 PM and 6:00 PM to minimize diurnal pressure variations. In studies using brinzolamide (1.0% soln) or timolol (0.5% soln) the drug was applied topically 2 hrs prior to measurement of IOP.

Results: : Best2-/- mice were found to have significantly (p<0.02) diminished IOP, (10.56 ± 0.21 mm Hg, n=39) in comparison to Best2+/+ (11.73 ± 0.37 mm Hg, n=12) and Best2+/- littermates (11.52 ± 0.44 mm Hg, n=20). There was no difference in episcleral venous pressure between genotypes with all having an EVP of 6.3 ± 0.3 mm Hg. Timolol and brinzolamide lowered IOP significantly in mice of all genotypes. While Timolol was equally effective on all genotypes, bringing IOP to ~9.5 mm Hg, brinzolamide lowered IOP in Best2-/- and Best2+/- mice by 0.5 and 0.7 mmHg more than in Best2+/+ mice. Pilot studies examining the inflow and outflow pathways suggest that the absence of Best2 results in changes to both the rate of aqueous formation and drainage.

Conclusions: : Based on these studies we conclude that Best2 plays a role in the generation of IOP by regulating formation of aqueous humor, and that the inhibition of Best2 function represents an attractive new avenue for regulating IOP in individuals with glaucoma.

Keywords: intraocular pressure • aqueous • ciliary body 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×